Comparison 7. (1.29) Mifepristone versus placebo: all women, previous caesarean section, unfavourable cervix.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
3 Caesarean section	2	76	Risk Ratio (M‐H, Fixed, 95% CI)	0.84 [0.44, 1.59]
7 Labour/cervical ripening within 96 hours	1	32	Risk Ratio (M‐H, Fixed, 95% CI)	5.5 [1.44, 20.96]
8 Neonatal hypoglycaemia	1	32	Risk Ratio (M‐H, Fixed, 95% CI)	3.0 [0.13, 68.57]
9 Uterine dehiscence/rupture	2	76	Risk Ratio (M‐H, Fixed, 95% CI)	1.31 [0.19, 9.25]
11 Instrumental vaginal delivery	1	32	Risk Ratio (M‐H, Fixed, 95% CI)	1.25 [0.41, 3.82]
16 Perinatal death	1	32	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
22 Other maternal side effects	1	28	Risk Ratio (M‐H, Fixed, 95% CI)	2.67 [0.27, 26.09]
23 Uterine hyperstimulation	1	32	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
26 Caesarean section for CTG abnormalities	1	32	Risk Ratio (M‐H, Fixed, 95% CI)	1.0 [0.16, 6.25]
27 Caesarean section for arrested labour	1	32	Risk Ratio (M‐H, Fixed, 95% CI)	0.5 [0.15, 1.66]